Both in Pharmaceuticals
Pacira BioSciences vs Innoviva
Over the past year PCRX returned +60.1% and INVA returned +25.8%; their daily moves had a correlation of 0.14.
PCRX +60.1% INVA +25.8%Growth of $1, one year, split-adjusted
| Metric | PCRX | INVA |
|---|---|---|
| Price | $36.40 | $20.97 |
| Market cap | $1.45B | $1.51B |
| Today | +0.25% | +1.11% |
| 1 month | +51.2% | +0.6% |
| 6 months | +55.4% | −12.3% |
| Year to date | +40.6% | +4.9% |
| 1 year | +63.5% | +23.8% |
| Revenue growth (YoY) | +6.2% | +19.3% |
| Gross margin | 77.0% | 81.3% |
| Net margin | 2.4% | −69.8% |
| P/E (TTM) | 99.2× | 4.2× |
| Price / sales | 1.9× | 3.4× |
| Net cash | -$112.1M | $319.0M |
| Dividend yield | — | — |
| Volatility (60d) | 82.8% | 22.7% |
| Short % of float | 21.2% | 9.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).